Morteza Bashash, Joseph M. Connors, Randy D. Gascoyne, Barbara Meissner, Johanna M. Schuetz, Stephen Leach, Graham W. Slack, Brian R. Berry, Howard Hu, Laurie H. Sehn, Angela R. Brooks-Wilson, and John J. Spinelli. 2017. “Genetic Polymorphism at BCL2 As a Predictor for Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone Efficacy in Patients With Diffuse Large B-Cell Lymphoma”. Haematologica 102 (5). Pavia, Italy, e199-e202. https://doi.org/10.3324/haematol.2016.159087.